Development. Validation. Accessibility.

Helping to Improve Patient Outcomes through Liquid Biopsy

  • Address liquid biopsy disparities today to ensure equity in outcomes tomorrow

    To ensure equity in liquid biopsy access, BLOODPAC's roadmap calls for diverse trials, payer engagement, and patient education to address key barriers.

    READ ARTICLE

  • Improving Cancer Care Requires Payers at the Table

    This white paper highlights the importance of payer engagement in ensuring patient access to liquid biopsy in cancer care.

    READ WHITE PAPER

Latest News & Updates

How We Work

EVIDENCE GENERATION

Align around a framework for evidence generation to bring liquid biopsy into routine clinical practice.

BLOODPAC PORTAL

Enable community storing, sharing and analysis of liquid biopsy datasets for the community.

STAKEHOLDER ENGAGEMENT

Accelerate approval through stakeholder engagement.

slideer-bw2-1.jpg
slideer-bw2-2.jpg
slideer-bw2-3.jpg
slideer-bw2-4.jpg

Ten Years of Progress in Five

BLOODPAC was launched as a commitment to the White House Cancer Moonshot to accelerate the development, validation, and clinical use of liquid biopsy assays to better inform medical decisions and ultimately improve patient care and outcomes. 

Five years later, members of the BLOODPAC Consortium came together to reflect on the journey and discuss the goals we’ve set for our next chapter.

Watch the event, learn more about our work and be a part of the Summit experience.